Ipatasertib Recruiting Phase 1 / 2 Trials for Estrogen Receptor Negative / Prognostic Stage IV Breast Cancer AJCC v8 / Anatomic Stage IV Breast Cancer AJCC v8 / Metastatic Triple-Negative Breast Carcinoma / Progesterone Receptor Negative / HER2/Neu Negative Treatment